Symbols / GDRX
GDRX Chart
About
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 823.46M |
| Enterprise Value | 1.08B | Income | 31.75M | Sales | 800.65M |
| Book/sh | 1.76 | Cash/sh | 0.81 | Dividend Yield | — |
| Payout | 0.00% | Employees | 738 | IPO | — |
| P/E | 29.62 | Forward P/E | 5.48 | PEG | — |
| P/S | 1.03 | P/B | 1.35 | P/C | — |
| EV/EBITDA | 8.11 | EV/Sales | 1.34 | Quick Ratio | 2.99 |
| Current Ratio | 3.11 | Debt/Eq | 90.75 | LT Debt/Eq | — |
| EPS (ttm) | 0.08 | EPS next Y | 0.43 | EPS Growth | -67.80% |
| Revenue Growth | 0.40% | Earnings | 2026-02-25 | ROA | 5.03% |
| ROE | 4.90% | ROIC | — | Gross Margin | 93.46% |
| Oper. Margin | 7.46% | Profit Margin | 3.97% | Shs Outstand | 105.47M |
| Shs Float | 92.55M | Short Float | 11.48% | Short Ratio | 4.66 |
| Short Interest | — | 52W High | 5.81 | 52W Low | 2.10 |
| Beta | 1.50 | Avg Volume | 2.55M | Volume | 2.20M |
| Target Price | $4.56 | Recom | None | Prev Close | $2.27 |
| Price | $2.37 | Change | 4.41% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$4.56
Mean price target
2. Current target
$2.37
Latest analyst target
3. DCF / Fair value
$18.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.37
Low
$2.60
High
$7.00
Mean
$4.56
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-22 | down | Jefferies | Buy → Hold | $3 |
| 2026-01-09 | main | Citigroup | Buy → Buy | $5 |
| 2025-12-18 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $4 |
| 2025-12-09 | init | Barclays | — → Underweight | $3 |
| 2025-11-11 | main | JP Morgan | Overweight → Overweight | $5 |
| 2025-11-10 | main | TD Cowen | Buy → Buy | $6 |
| 2025-11-06 | main | UBS | Neutral → Neutral | $4 |
| 2025-11-06 | main | Mizuho | Neutral → Neutral | $4 |
| 2025-08-11 | main | UBS | Neutral → Neutral | $4 |
| 2025-05-13 | main | UBS | Neutral → Neutral | $5 |
| 2025-05-09 | main | Goldman Sachs | Neutral → Neutral | $5 |
| 2025-04-29 | main | Wells Fargo | Overweight → Overweight | $7 |
| 2025-04-10 | main | Truist Securities | Hold → Hold | $6 |
| 2025-02-28 | main | Wells Fargo | Overweight → Overweight | $8 |
| 2025-01-10 | main | Citigroup | Buy → Buy | $6 |
| 2025-01-08 | main | Keybanc | Overweight → Overweight | $6 |
| 2024-12-17 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $6 |
| 2024-11-13 | main | Citigroup | Buy → Buy | $7 |
| 2024-11-11 | main | Barclays | Overweight → Overweight | $6 |
| 2024-08-16 | reit | RBC Capital | Outperform → Outperform | $10 |
- Employers get new way to cut Wegovy and GLP-1 costs with GoodRx - Stock Titan ue, 24 Feb 2026 14
- GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st Mon, 19 Jan 2026 08
- GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect - TradingView ue, 24 Feb 2026 03
- $GDRX stock is down 9% today. Here's what we see in our data. - Quiver Quantitative Mon, 09 Feb 2026 08
- Why GoodRx (GDRX) Stock Is Trading Lower Today - Yahoo Finance ue, 09 Dec 2025 08
- GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 106% Upside Potential Amid Healthcare Industry Dynamics - DirectorsTalk Interviews ue, 10 Feb 2026 08
- Should You Buy GoodRx Stock? - Forbes ue, 04 Nov 2025 08
- Why GoodRx (GDRX) Stock Is Trading Up Today - Yahoo Finance Mon, 18 Aug 2025 07
- $GDRX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative hu, 02 Oct 2025 07
- Major Pharmacy Breakthrough: GoodRx Brings Instant Brand Drug Savings to 2,200 Kroger Stores in 35 States - Stock Titan Wed, 01 Oct 2025 07
- Why GoodRx (GDRX) Stock Is Up Today - TradingView Fri, 03 Oct 2025 07
- GoodRx (GDRX) Stock Is Up, What You Need To Know - Yahoo Finance ue, 26 Aug 2025 07
- $GDRX stock is up 31% today. Here's what we see in our data. - Quiver Quantitative Mon, 18 Aug 2025 07
- A Look at GoodRx (GDRX) Valuation Following a 27% One-Month Share Price Decline - Yahoo Finance Sun, 09 Nov 2025 08
- Why GoodRx (GDRX) Shares Are Sliding Today - Yahoo Finance Fri, 05 Sep 2025 07
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 4804 | — | — | NABIEY ROMIN | Officer | — | 2026-02-13 00:00:00 | D | nan |
| 1 | 179120 | — | — | MCGINNIS CHRISTOPHER ALAN | Officer | — | 2026-02-13 00:00:00 | D | nan |
| 2 | 12663 | — | — | NABIEY ROMIN | Officer | — | 2026-02-06 00:00:00 | D | nan |
| 3 | 31394 | — | — | WAGNER SCOTT W. | Director | — | 2026-01-21 00:00:00 | D | nan |
| 4 | 665302 | — | — | BARNES WENDY LYNN | Officer and Director | — | 2026-01-15 00:00:00 | D | nan |
| 5 | 18251 | — | Stock Award(Grant) at price 0.00 per share. | BRUEHLMAN RONALD E | Director | — | 2025-12-31 00:00:00 | D | — |
| 6 | 10950 | — | Stock Award(Grant) at price 0.00 per share. | HIRSCH DOUGLAS JOSEPH | Director | — | 2025-12-31 00:00:00 | D | — |
| 7 | 23149 | — | — | KENNEDY KELLY J | Director | — | 2025-12-19 00:00:00 | D | nan |
| 8 | 12432 | — | — | NABIEY ROMIN | Officer | — | 2025-12-08 00:00:00 | D | nan |
| 9 | 4804 | — | — | NABIEY ROMIN | Officer | — | 2025-11-14 00:00:00 | D | nan |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -436.17K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | 156.00M | 108.82M | 65.19M | 48.00M |
| TotalUnusualItems | -2.08M | 0.00 | 0.00 | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -2.08M | 0.00 | 0.00 | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | 16.39M | -8.87M | -32.83M | -25.25M |
| ReconciledDepreciation | 69.54M | 107.67M | 54.18M | 34.54M |
| ReconciledCostOfRevenue | 48.22M | 66.92M | 65.08M | 46.72M |
| EBITDA | 153.92M | 108.82M | 65.19M | 48.00M |
| EBIT | 84.38M | 1.16M | 11.01M | 13.46M |
| NetInterestIncome | -29.65M | -24.56M | -24.97M | -23.58M |
| InterestExpense | 52.92M | 56.73M | 34.24M | 23.64M |
| InterestIncome | 23.27M | 32.17M | 9.27M | 59.00K |
| NormalizedIncome | 18.03M | -8.87M | -32.83M | -25.25M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 16.39M | -8.87M | -32.83M | -25.25M |
| TotalExpenses | 726.48M | 777.27M | 764.82M | 732.02M |
| TotalOperatingIncomeAsReported | 65.85M | -27.01M | 1.74M | 13.41M |
| DilutedAverageShares | 392.17M | 410.31M | 412.86M | 409.98M |
| BasicAverageShares | 385.74M | 410.31M | 412.86M | 409.98M |
| DilutedEPS | 0.04 | -0.02 | -0.08 | -0.06 |
| BasicEPS | 0.04 | -0.02 | -0.08 | -0.06 |
| DilutedNIAvailtoComStockholders | 16.39M | -8.87M | -32.83M | -25.25M |
| AverageDilutionEarnings | 0.00 | |||
| NetIncomeCommonStockholders | 16.39M | -8.87M | -32.83M | -25.25M |
| OtherunderPreferredStockDividend | 0.00 | 0.00 | ||
| NetIncome | 16.39M | -8.87M | -32.83M | -25.25M |
| NetIncomeIncludingNoncontrollingInterests | 16.39M | -8.87M | -32.83M | -25.25M |
| NetIncomeContinuousOperations | 16.39M | -8.87M | -32.83M | -25.25M |
| TaxProvision | 15.07M | -46.70M | 9.60M | 15.08M |
| PretaxIncome | 31.46M | -55.57M | -23.23M | -10.18M |
| OtherIncomeExpense | -4.74M | -4.01M | ||
| OtherNonOperatingIncomeExpenses | -2.66M | -4.01M | ||
| SpecialIncomeCharges | -2.08M | 0.00 | 0.00 | 0.00 |
| OtherSpecialCharges | 2.08M | |||
| NetNonOperatingInterestIncomeExpense | -29.65M | -24.56M | -24.97M | -23.58M |
| InterestExpenseNonOperating | 52.92M | 56.73M | 34.24M | 23.64M |
| InterestIncomeNonOperating | 23.27M | 32.17M | 9.27M | 59.00K |
| OperatingIncome | 65.85M | -27.01M | 1.74M | 13.41M |
| OperatingExpense | 678.26M | 710.35M | 699.74M | 685.30M |
| DepreciationAmortizationDepletionIncomeStatement | 69.54M | 107.67M | 54.18M | 34.54M |
| DepreciationAndAmortizationInIncomeStatement | 69.54M | 107.67M | 54.18M | 34.54M |
| ResearchAndDevelopment | 123.75M | 135.84M | 143.14M | 125.86M |
| SellingGeneralAndAdministration | 484.98M | 466.84M | 502.42M | 524.90M |
| SellingAndMarketingExpense | 367.11M | 341.33M | 357.63M | 370.22M |
| GeneralAndAdministrativeExpense | 117.86M | 125.52M | 144.79M | 154.69M |
| OtherGandA | 117.86M | 125.52M | 144.79M | 154.69M |
| GrossProfit | 744.11M | 683.34M | 701.48M | 698.71M |
| CostOfRevenue | 48.22M | 66.92M | 65.08M | 46.72M |
| TotalRevenue | 792.32M | 750.26M | 766.55M | 745.42M |
| OperatingRevenue | 771.32M | 730.21M | 746.13M | 726.63M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 382.81M | 394.09M | 397.02M | 400.56M |
| ShareIssued | 382.81M | 394.09M | 397.02M | 400.56M |
| NetDebt | 43.37M | |||
| TotalDebt | 543.39M | 711.07M | 717.02M | 702.33M |
| TangibleBookValue | 137.01M | 194.85M | 212.77M | 368.21M |
| InvestedCapital | 1.22B | 1.42B | 1.47B | 1.49B |
| WorkingCapital | 535.35M | 750.23M | 843.37M | 1.01B |
| NetTangibleAssets | 137.01M | 194.85M | 212.77M | 368.21M |
| CapitalLeaseObligations | 51.68M | 54.58M | 58.20M | 39.44M |
| CommonStockEquity | 724.66M | 761.96M | 814.83M | 831.68M |
| TotalCapitalization | 1.21B | 1.41B | 1.47B | 1.49B |
| TotalEquityGrossMinorityInterest | 724.66M | 761.96M | 814.83M | 831.68M |
| StockholdersEquity | 724.66M | 761.96M | 814.83M | 831.68M |
| RetainedEarnings | -1.44B | -1.46B | -1.45B | -1.42B |
| AdditionalPaidInCapital | 2.17B | 2.22B | 2.26B | 2.25B |
| CapitalStock | 38.00K | 40.00K | 40.00K | 40.00K |
| CommonStock | 38.00K | 40.00K | 40.00K | 40.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 663.41M | 826.84M | 789.80M | 775.95M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 539.51M | 704.28M | 713.48M | 694.83M |
| OtherNonCurrentLiabilities | 6.75M | 8.18M | 7.56M | 5.38M |
| NonCurrentDeferredLiabilities | 244.00K | |||
| NonCurrentDeferredTaxesLiabilities | 244.00K | |||
| LongTermDebtAndCapitalLeaseObligation | 532.75M | 696.11M | 705.93M | 689.45M |
| LongTermCapitalLeaseObligation | 46.04M | 48.40M | 54.13M | 33.59M |
| LongTermDebt | 486.71M | 647.70M | 651.80M | 655.86M |
| CurrentLiabilities | 123.90M | 122.56M | 76.32M | 81.11M |
| OtherCurrentLiabilities | 15.80M | |||
| CurrentDeferredLiabilities | 6.04M | 7.11M | 7.88M | 6.87M |
| CurrentDeferredRevenue | 6.04M | 7.11M | 7.88M | 6.87M |
| CurrentDebtAndCapitalLeaseObligation | 10.64M | 14.96M | 11.10M | 12.88M |
| CurrentCapitalLeaseObligation | 5.64M | 6.18M | 4.07M | 5.85M |
| CurrentDebt | 5.00M | 8.79M | 7.03M | 7.03M |
| OtherCurrentBorrowings | 5.00M | 8.79M | 7.03M | 7.03M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 30.40M | 20.64M | 24.03M | |
| PayablesAndAccruedExpenses | 91.43M | 100.49M | 57.34M | 61.36M |
| CurrentAccruedExpenses | 75.84M | 64.22M | 39.64M | 43.86M |
| Payables | 15.59M | 36.27M | 17.70M | 17.50M |
| TotalTaxPayable | 1.46M | 0.00 | ||
| IncomeTaxPayable | 1.46M | 0.00 | ||
| AccountsPayable | 14.14M | 36.27M | 17.70M | 17.50M |
| TotalAssets | 1.39B | 1.59B | 1.60B | 1.61B |
| TotalNonCurrentAssets | 728.81M | 716.01M | 684.95M | 518.80M |
| OtherNonCurrentAssets | 23.52M | 37.77M | 27.16M | 6.01M |
| NonCurrentDeferredAssets | 77.18M | 65.27M | 0.00 | 0.00 |
| NonCurrentDeferredTaxesAssets | 77.18M | 65.27M | 0.00 | 0.00 |
| GoodwillAndOtherIntangibleAssets | 587.65M | 567.11M | 602.05M | 463.47M |
| OtherIntangibleAssets | 176.88M | 156.34M | 189.94M | 133.78M |
| Goodwill | 410.77M | 410.77M | 412.12M | 329.70M |
| NetPPE | 40.46M | 45.86M | 55.73M | 49.32M |
| AccumulatedDepreciation | -18.23M | -13.79M | -9.77M | -5.83M |
| GrossPPE | 58.69M | 59.65M | 65.50M | 55.15M |
| Leases | 16.17M | 16.00M | 16.09M | 15.35M |
| ConstructionInProgress | 308.00K | 169.00K | 0.00 | 361.00K |
| OtherProperties | 27.79M | 29.93M | 35.91M | 27.70M |
| MachineryFurnitureEquipment | 14.42M | 13.55M | 13.49M | 11.73M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 659.25M | 872.79M | 919.69M | 1.09B |
| OtherCurrentAssets | 50.08M | 40.45M | 35.10M | 21.31M |
| RestrictedCash | 0.00 | |||
| PrepaidAssets | 0.00 | 5.75M | 0.00 | |
| Receivables | 160.83M | 160.04M | 121.67M | 126.41M |
| OtherReceivables | 14.90M | 12.90M | ||
| TaxesReceivable | 0.00 | 3.54M | 4.52M | 8.33M |
| AccountsReceivable | 145.93M | 143.61M | 117.14M | 118.08M |
| CashCashEquivalentsAndShortTermInvestments | 448.35M | 672.30M | 757.16M | 941.11M |
| CashAndCashEquivalents | 448.35M | 672.30M | 757.16M | 941.11M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 113.55M | 82.53M | 91.57M | 144.32M |
| RepurchaseOfCapitalStock | -158.84M | -103.97M | -101.72M | 0.00 |
| RepaymentOfDebt | -639.04M | -5.27M | -7.03M | -7.03M |
| IssuanceOfDebt | 472.03M | 0.00 | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 0.00 | 0.00 | ||
| CapitalExpenditure | -70.35M | -55.77M | -55.21M | -34.46M |
| InterestPaidSupplementalData | 55.10M | 48.80M | 30.70M | 20.20M |
| IncomeTaxPaidSupplementalData | 23.62M | 17.24M | 4.36M | 18.11M |
| EndCashPosition | 448.35M | 672.30M | 757.16M | 941.11M |
| BeginningCashPosition | 672.30M | 757.16M | 941.11M | 971.59M |
| ChangesInCash | -223.95M | -84.87M | -183.94M | -30.48M |
| FinancingCashFlow | -337.50M | -167.40M | -120.23M | -30.53M |
| CashFlowFromContinuingFinancingActivities | -337.50M | -167.40M | -120.23M | -30.53M |
| NetOtherFinancingCharges | -32.46M | -65.48M | -20.64M | -58.52M |
| ProceedsFromStockOptionExercised | 20.81M | 7.33M | 9.16M | 35.02M |
| NetCommonStockIssuance | -158.84M | -103.97M | -101.72M | 0.00 |
| CommonStockPayments | -158.84M | -103.97M | -101.72M | 0.00 |
| CommonStockIssuance | 0.00 | 0.00 | ||
| NetIssuancePaymentsOfDebt | -167.00M | -5.27M | -7.03M | -7.03M |
| NetLongTermDebtIssuance | -167.00M | -5.27M | -7.03M | -7.03M |
| LongTermDebtPayments | -639.04M | -5.27M | -7.03M | -7.03M |
| LongTermDebtIssuance | 472.03M | 0.00 | 0.00 | 0.00 |
| InvestingCashFlow | -70.35M | -55.77M | -210.50M | -178.73M |
| CashFlowFromContinuingInvestingActivities | -70.35M | -55.77M | -210.50M | -178.73M |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | -155.28M | -144.28M |
| SaleOfBusiness | 0.00 | 0.00 | 16.58M | 0.00 |
| PurchaseOfBusiness | 0.00 | 0.00 | -171.86M | -144.28M |
| NetPPEPurchaseAndSale | -1.24M | -1.04M | -3.97M | -4.57M |
| PurchaseOfPPE | -1.24M | -1.04M | -3.97M | -4.57M |
| CapitalExpenditureReported | -69.11M | -54.72M | -51.25M | -29.89M |
| OperatingCashFlow | 183.89M | 138.29M | 146.78M | 178.78M |
| CashFlowFromContinuingOperatingActivities | 183.89M | 138.29M | 146.78M | 178.78M |
| ChangeInWorkingCapital | 2.09M | -21.94M | -20.29M | -11.80M |
| ChangeInOtherCurrentLiabilities | -6.38M | -2.02M | -1.88M | -3.12M |
| ChangeInPayablesAndAccruedExpense | 4.47M | 38.71M | -6.14M | 18.21M |
| ChangeInAccruedExpense | 25.71M | 21.25M | -5.27M | 14.00M |
| ChangeInPayable | -21.24M | 17.46M | -874.00K | 4.21M |
| ChangeInAccountPayable | -21.24M | 17.46M | -874.00K | 4.21M |
| ChangeInPrepaidAssets | 6.33M | -32.16M | -13.64M | 17.06M |
| ChangeInReceivables | -2.33M | -26.47M | 1.38M | -43.95M |
| ChangesInAccountReceivables | -2.33M | -26.47M | 1.38M | -43.95M |
| OtherNonCashItems | 6.68M | 12.84M | 24.82M | 6.55M |
| StockBasedCompensation | 99.03M | 104.82M | 120.23M | 160.46M |
| DeferredTax | -11.91M | -65.56M | -497.00K | 12.85M |
| DeferredIncomeTax | -11.91M | -65.56M | -497.00K | 12.85M |
| DepreciationAmortizationDepletion | 69.54M | 107.67M | 54.18M | 34.54M |
| DepreciationAndAmortization | 69.54M | 107.67M | 54.18M | 34.54M |
| AmortizationCashFlow | 102.90M | |||
| AmortizationOfIntangibles | 102.90M | |||
| Depreciation | 4.80M | |||
| OperatingGainsLosses | 2.08M | 9.33M | 1.17M | 1.43M |
| EarningsLossesFromEquityInvestments | 4.01M | 0.00 | 0.00 | |
| GainLossOnSaleOfPPE | 0.00 | 7.97M | 0.00 | 1.43M |
| GainLossOnSaleOfBusiness | 0.00 | 0.00 | -11.40M | 0.00 |
| NetIncomeFromContinuingOperations | 16.39M | -8.87M | -32.83M | -25.25M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for GDRX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|